Inari Medical (NARI) was surging late in Monday trading after Reuters reported that the venous therapies company was in advanced discussions for a potential acquisition by medical device maker Stryker, citing people familiar with the matter.
A deal, if successful, could be announced as soon as this week, according to the report.
Inari, which has a market value of about $3.8 billion, has been working with advisers to explore a sale after receiving acquisition interest from Stryker and other parties, the report added, citing sources.
The report did not specify an exact offer price for Inari, whose stock was trading 28% higher just before Monday's close.
Inari Medical and Stryker did not immediately respond to MT Newswires' request for comment Monday afternoon.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 63.82, Change: +14.05, Percent Change: +28.22
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.